Aceso Life Science Group Limited (HKG:0474)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1140
0.00 (0.00%)
Jun 30, 2026, 3:59 PM HKT

Aceso Life Science Group Financials Overview

Millions HKD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
-56-7111207170-129
Revenue Growth
---94.69%21.77%--
Operating Income
-307-290-224-90-136-466
Net Income
-372-895-462-264-370-376
Earnings Per Share
-0.05-0.12-0.06-0.04-0.06-0.06
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Property Leasing
402529314542
Rental and Sale of Construction Machinery and Spare Parts
-133153227165142
Provision of Repair and Maintenance and Transportation Service
-668108
Money Lending
--56-85304686
Provision of Asset Management, Securities Brokerage and Other Financial Services
-10714149
Unallocated Finance Costs
--96-111-101-126-155
Unallocated Reversal of Impairment Losses of Financial Assets (Expected Credit Losses)
--9414911-257
Total
-57-7213218165-125

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Investments
305212469602717786
Total Debt
1,2282,3012,7382,9223,0102,872
Net Cash (Debt)
-923-2,089-2,269-2,320-2,293-2,086
Net Cash Growth
------
Net Cash Per Share
-0.13-0.29-0.31-0.32-0.31-0.30

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Cash Flow
11517-37214316179
Capital Expenditures
1-2-11-24-57-15
Free Cash Flow
11615-48190259164
Free Cash Flow Growth
673.33%---26.64%57.93%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Margin
---2036.36%-43.48%-80.00%-
Pretax Margin
930.36%1446.48%-7481.82%-102.90%-326.47%250.39%
Profit Margin
---4200.00%-127.54%-217.65%-
FCF Margin
---436.36%91.79%152.35%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
P/FCF Ratio
8.7124.61-6.921.829.60
PS Ratio
-18.03-5.20106.706.352.78-12.20